Total Funding
3
1
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-56 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
697056
Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases.
Kenneth A. Cawkell: Chief Executive Officer
Denis Kay: Founder & Chief Scientific officer
About the Company
Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases. Its product pipeline comprises ND-1004, a natural product based neuro-protectant for early-stage treatment of Parkinson's disease.
It was founded in 2009 and is headquartered in Vancouver, British Columbia.
